Vimarsana.com

Latest Breaking News On - Actinium pharmaceuticals price performance - Page 1 : vimarsana.com

HC Wainwright Reaffirms Buy Rating for Actinium Pharmaceuticals (NYSEAMERICAN:ATNM)

HC Wainwright reiterated their buy rating on shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $50.00 target price on the biotechnology company’s stock. Several other research analysts also recently commented on ATNM. Cantor Fitzgerald reaffirmed an overweight rating […]

Actinium-pharmaceuticals-company-profile
Sanders-morris-harris
News-ratings-for-actinium-pharmaceuticals-daily
Maxim-group
Cantor-fitzgerald
Actinium-pharmaceuticals-inc
Creative-financial-designs-inc
Actinium-pharmaceuticals
Vanguard-group-inc
Virtu-financial
Actinium-pharmaceuticals-price-performance

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Rating Reiterated by HC Wainwright

HC Wainwright reiterated their buy rating on shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Free Report) in a report published on Tuesday morning, Benzinga reports. The brokerage currently has a $50.00 target price on the biotechnology company’s stock. Other analysts have also recently issued reports about the stock. Stephens initiated coverage on shares of Actinium Pharmaceuticals […]

Vanguard-group-inc
Sanders-morris-harris
Institutional-investors-weigh-in-on-actinium-pharmaceuticals
Actinium-pharmaceuticals-company-profile
News-ratings-for-actinium-pharmaceuticals-daily
Cantor-fitzgerald
Actinium-pharmaceuticals
Creative-financial-designs-inc
Virtu-financial
Analyst-recommendations-for-actinium-pharmaceuticals
Actinium-pharmaceuticals-price-performance

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Given "Overweight" Rating at Cantor Fitzgerald

Cantor Fitzgerald reissued their overweight rating on shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Free Report) in a research report report published on Tuesday morning, Benzinga reports. The firm currently has a $21.00 target price on the biotechnology company’s stock. Cantor Fitzgerald also issued estimates for Actinium Pharmaceuticals’ FY2024 earnings at ($1.35) EPS. Several other analysts […]

Actinium-pharmaceuticals
Actinium-pharmaceuticals-price-performance
Actinium-pharmaceuticals-inc
Analyst-recommendations-for-actinium-pharmaceuticals
Maxim-group
Cantor-fitzgerald
Creative-financial-designs-inc
News-ratings-for-actinium-pharmaceuticals-daily
Brandywine-global-investment-management
Sanders-morris-harris
Free-report

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Upgraded to "Hold" at StockNews.com

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Upgraded to "Hold" at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Maxim-group
Actinium-pharmaceuticals-price-performance
News-ratings-for-actinium-pharmaceuticals-daily
Cantor-fitzgerald
Sanders-morris-harris
Brandywine-global-investment-management
Actinium-pharmaceuticals
Actinium-pharmaceuticals-inc
Analyst-recommendations-for-actinium-pharmaceuticals
Creative-financial-designs-inc
Free-report

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Trading Down 7.1%

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Trading Down 7.1%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Actinium-pharmaceuticals-price-performance
Actinium-pharmaceuticals
Cantor-fitzgerald
News-ratings-for-actinium-pharmaceuticals-daily
Actinium-pharmaceuticals-company-profile
Brandywine-global-investment-management
Actinium-pharmaceuticals-inc
Maxim-group
Creative-financial-designs-inc
Sanders-morris-harris
Get-free-report

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Given "Buy" Rating at HC Wainwright

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Given "Buy" Rating at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
California
United-states
Manufacturers-life-insurance-company
Actinium-pharmaceuticals
News-ratings-for-actinium-pharmaceuticals-daily
Royal-bank
Actinium-pharmaceuticals-company-profile
Actinium-pharmaceuticals-price-performance
Maxim-group
Deutsche-bank

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Stock Price Up 5.2%

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Stock Price Up 5.2%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

California
United-states
Canada
Boothbay
Saskatchewan
Royal-bank
Boothbay-fund-management
Actinium-pharmaceuticals-inc
News-ratings-for-actinium-pharmaceuticals-daily
Actinium-pharmaceuticals
Manufacturers-life-insurance-company

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Free Report) in a research report report published on Wednesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, HC Wainwright cut their price target on Actinium Pharmaceuticals from $53.00 to $50.00 and set a buy rating on the stock in […]

California
United-states
Canada
Royal-bank
Manufacturers-life-insurance-company
Actinium-pharmaceuticals
Quent-capital
Actinium-pharmaceuticals-inc
Actinium-pharmaceuticals-company-profile
Actinium-pharmaceuticals-price-performance
News-ratings-for-actinium-pharmaceuticals-daily

William Blair Comments on Actinium Pharmaceuticals, Inc.'s Q3 2023 Earnings (NYSEAMERICAN:ATNM)

Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Free Report) – Equities researchers at William Blair decreased their Q3 2023 earnings per share estimates for shares of Actinium Pharmaceuticals in a report released on Tuesday, August 15th. William Blair analyst A. Hsieh now forecasts that the biotechnology company will post earnings of ($0.73) per share for the quarter, […]

Canada
United-states
American
William-blair
Actinium-pharmaceuticals-company-profile
Institutional-investors-weigh-in-on-actinium-pharmaceuticals
Royal-bank
Quent-capital
American-international-group-inc
News-ratings-for-actinium-pharmaceuticals-daily
Actinium-pharmaceuticals-inc
Actinium-pharmaceuticals

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Posts Earnings Results, Misses Expectations By $0.08 EPS

Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Posts Earnings Results, Misses Expectations By $0.08 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
Nuveen-asset-management
Hedge-funds-weigh-in-on-actinium-pharmaceuticals
Actinium-pharmaceuticals-inc
Wells-fargo-company
Royal-bank
Actinium-pharmaceuticals
Actinium-pharmaceuticals-price-performance
News-ratings-for-actinium-pharmaceuticals-daily
Earnings-history-for-actinium-pharmaceuticals
Get-free-report

vimarsana © 2020. All Rights Reserved.